info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Lomitapide (Juxtapid)
501
Article source: Seagull Pharmacy
Oct 22, 2025

Lomitapide (Juxtapid) is a medication used to treat specific lipid metabolism disorders, with lomitapide as its active ingredient.

Indications for Lomitapide (Juxtapid)

Primary Therapeutic Uses

Lomitapide (Juxtapid) capsules are mainly used for the treatment of adult patients with homozygous familial hypercholesterolemia (HoFH).

This is a rare genetic disorder that causes abnormally elevated levels of low-density lipoprotein cholesterol (LDL-C) in the blood.

As an adjunct to diet and other lipid-lowering therapies, this medication is indicated for HoFH patients whose LDL-C levels cannot be adequately controlled with existing treatments.

Usage Restrictions

It must be used in combination with other lipid-lowering therapies (such as statins, LDL apheresis).

It is not indicated for patients with heterozygous familial hypercholesterolemia (HeFH).

It must be used under the guidance of physicians experienced in the treatment of HoFH.

Specifications and Properties of Lomitapide (Juxtapid)

Dosage Form and Strengths

5mg capsules: Opaque white capsule bodies with opaque purple capsule caps, imprinted with "A5".

10mg capsules: Opaque white capsule bodies with opaque orange capsule caps, imprinted with "A10".

20mg capsules: Opaque orange capsule bodies with opaque orange capsule caps, imprinted with "A20".

Composition

Active ingredient: Lomitapide (present as lomitapide mesylate).

Excipients: Pregelatinized starch, magnesium stearate, silicon dioxide, etc.

Packaging Information

Aluminum-plastic blister packaging.

Each box contains 30 capsules.

A desiccant is included to maintain stability.

Storage Methods for Lomitapide (Juxtapid)

Basic Storage Conditions

Temperature requirement: Store at 20-25°C, with short-term fluctuations of 15-30°C allowed.

Light protection requirement: Keep in the original packaging to avoid direct sunlight.

Moisture-proof measure: Tightly close the bottle cap immediately after use.

Special Precautions

Do not transfer the medication to other containers for storage.

Keep away from humid environments (such as bathrooms).

Store out of the reach of children.

Expired medications should be disposed of in accordance with local regulations.

Travel Carrying Recommendations

It can be carried with you during short trips.

For long trips, it is recommended to use the original packaging and place it in an insulated bag.

Do not place the medication in checked luggage.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase Lomitapide Capsules (Juxtapid)
Lomitapide Capsules (Juxtapid) are an oral microsomal triglyceride transfer protein (MTP) inhibitor indicated for the treatment of homozygous familial hypercholesterolemia (HoFH). Due to the drug’s sp...
What Are the Side Effects of Risdiplam Tablets (Evrysdi)?
Risdiplam Tablets (Evrysdi) are an SMN2 splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in children and adults. Available as an oral solution or tablets, its clinical us...
Precautions for Risdiplam Tablets (Evrysdi) Administration
Risdiplam Tablets (Evrysdi) are an oral SMN2 splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. As a targeted therapeutic drug requiring lo...
How to Use Risdiplam Tablets (Evrysdi)
As the first oral SMN2 splicing modifier, Risdiplam Tablets (Evrysdi) provide an innovative treatment option for patients with spinal muscular atrophy (SMA).How to Use Risdiplam Tablets (Evrysdi)1. Ro...
How to Use Lomitapide (Juxtapid)
Lomitapide (Juxtapid) is a microsomal triglyceride transfer protein (MTP) inhibitor, used for the treatment of homozygous familial hypercholesterolemia (HoFH).How to Use Lomitapide (Juxtapid)Standard ...
What Are the Side Effects of Alemtuzumab Injection (Lemtrada)?
Alemtuzumab Injection (Lemtrada) is a CD52-directed cytolytic monoclonal antibody used for the treatment of relapsing multiple sclerosis (MS). Despite its significant efficacy, this medication may cau...
Indications for Risdiplam Tablets (Evrysdi)
Risdiplam Tablets (Evrysdi) is an SMN2 splicing modifier used for the treatment of adult and pediatric patients with spinal muscular atrophy (SMA). As a breakthrough drug in the field of gene therapy,...
How to Purchase Decitabine and Cedazuridine Combination Tablets (INQOVI)
Decitabine and Cedazuridine Combination Tablets (INQOVI) are a prescription medication used for the treatment of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). Due to its ...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved